Medication orders become final once the provider approves the prescription and it's submitted to the pharmacy
Results-Driven: With Herrman & Herrman P.L.L.C., you gain a dedicated partner focused on achieving favorable outcomes for our clients
Judge Marston has scheduled an evidentiary hearing for May 14, 2025, to evaluate scientific evidence linking the drugs to gastroparesis and other gastrointestinal issues, such as small bowel obstruction and gallbladder injuries
The small molecule inhibitors or gene silencing of GLS1 expression has shown antitumor activity in a variety of cancers, including melanoma (Varghese et al., 2021), breast cancer (Gross et al., 2014), pancreatic cancer (Son et al., 2013), acute myeloid leukemia (Emadi et al., 2014), and malignant glioma (Yamashita et al., 2021)
Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
Ribupatide vs Tirzepatide: Emerging Dual GIP/GLP-1 vs Approved Leader Evidence-based comparison of ribupatide (dual GLP-1/GIP agonist) and tirzepatide (dual GIP/GLP-1 agonist), including injectable, oral, and Phase 3 KaiNETIC program data
